Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows provided by (used in) operating activities:
Net income (loss)	$ 245	$ (687)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	297	318
Accretion of financing instruments	177	160
Change in fair value of derivative instruments	(19)	602
Impairment charge on investment in iBio, Inc.		139
(Gain) loss on sale of fixed assets	(4)	6
Decrease (increase) in:
Accounts receivable	479	176
Inventories	1,763	(1,456)
Other current assets	(30)	47
Security deposits and other assets	4	50
(Decrease) increase in:
Accounts payable	(977)	39
Accrued expenses and other liabilities	162	(252)
Net cash provided by (used in) operating activities	2,097	(858)
Cash flows from investing activities:
Purchase of property and equipment	(115)	(21)
Proceeds from sale of property and equipment		18
Net cash used in investing activities	(115)	(3)
Cash flows from financing activities:
Advances under revolving credit facility	24,133	25,342
Repayments under revolving credit facility	(25,255)	(23,977)
Payments under term notes	(699)	(361)
Payments under capital lease obligations	(32)	(3)
Net cash (used in) provided by financing activities	(1,853)	1,001
Net increase in cash	129	140
Cash at beginning of period	55	145
Cash at end of period	184	285
Cash paid during the periods for:
Interest	537	486
Income taxes	7	15
Financing on capitalized lease obligations	$ 76	$ 68